Loading organizations...
Loading organizations...
Biopharmaceutical company developing novel treatments for cancer.
OncoC4 has raised $50.0M across 1 funding round.
OncoC4 has raised $50.0M in total across 1 funding round.
OncoC4 has raised $50.0M in total across 1 funding round.
OncoC4's investors include GBA Fund, 3E Bioventures Capital, HM Capital, Kaitai Capital.
OncoC4 has raised $50.0M across 1 funding round. Most recently, it raised $50.0M Series B in October 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 2, 2025 | $50.0M Series B | GBA Fund | 3E Bioventures Capital, HM Capital, Kaitai Capital |